CADL
Candel TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
CADL vs peer average
79/100
CADL vs. peer average (A vs. C)
Grade spread
A 4 · B 1 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Aclaris is a loose small-cap biotech peer that is useful mainly for comparing clinical-timeline and financing sensitivity rather than mechanism or commercial setup.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CADL
Candel Therapeutics
ACRS
Aclaris Therapeutics
Grade
A
A
Momentum
94
88
Value
41
41
Sentiment
55
68
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ACRS
CADL / ACRS
Grade Position
Above peers
CADL vs. peer average (A vs. C)
79/100
Momentum
94
CADLValue
41
CADLSentiment
55
ACRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CADL
ACRS is the first peer returned for this comparison set.